USPatent applicationPatented

Microbicidal composition

Granted 25 Feb 2014 · 2 office actions

Current assignee: Rohm And Haas Company · originally DuPont

Law firm: Law firm · Log in to unlock

Attorney: Attorney · Log in to unlock

Inventors: Beverly Jean El A'mma, Beat Heer, Kiran Pareek, John William Ashmore · Examiner: Daniel Sullivan · AU 1611 · TC 1600

Life of the application

13 dated events
⤢ drag to zoom20082010201220142016201820202022202420262028ProsecutionOwnershipTerm & fees
ProsecutionOwnershipTerm & feeshover for detail · click to open

Abstract

Synergistic microbicidal compositions containing N-methyl-1,2-benzisothiazolin-3-one.

Description

5 parts
›This application claims the benefit of priority under…

This application claims the benefit of priority under 35 U.S.C. §119(e) of U.S. Provisional Patent Application No. 60/936,564 filed on Jun. 21, 2007.

This invention relates to a synergistic combination of selected microbicides having greater activity than would be observed for the individual microbicides.

In some cases, commercial microbicides cannot provide effective control of microorganisms, even at high use concentrations, due to weak activity against certain types of microorganisms, e.g., those resistant to some microbicides, or due to aggressive environmental conditions. Combinations of different microbicides are sometimes used to provide overall control of microorganisms in a particular end use environment. For example, U.S. Pat. App. Pub. No. 2007/0078118 discloses synergistic combinations of N-methyl-1,2-benzisothiazolin-3-one (MBIT) with other biocides. However, there is a need for additional combinations of microbicides having enhanced activity against various strains of microorganisms to provide effective control of the microorganisms. Moreover, there is a need for combinations containing lower levels of individual microbicides for environmental and economic benefit. The problem addressed by this invention is to provide such additional combinations of microbicides.

›STATEMENT OF THE INVENTION

The present invention is directed to a microbicidal composition comprising: (a) N-methyl-1,2-benzisothiazolin-3-one; and (b) at least one microbicide selected from among 2,2-dibromo-3-nitrilopropionamide, formaldehyde, 2-N-octyl-4-isothiazolin-3-one, propiconazole, tebuconazole, and a mixture of chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one.

›DETAILED DESCRIPTION OF THE INVENTION · 1 of 2

As used herein, the following terms have the designated definitions, unless the context clearly indicates otherwise. “MBIT” is N-methyl-1,2-benzisothiazolin-3-one. The term “microbicide” refers to a compound capable of killing, inhibiting the growth of or controlling the growth of microorganisms at a locus; microbicides include bactericides, fungicides and algaecides. The term “microorganism” includes, for example, fungi (such as yeast and mold), bacteria and algae. The term “locus” refers to an industrial system or product subject to contamination by microorganisms. The following abbreviations are used throughout the specification: ppm=parts per million by weight (weight/weight), mL=milliliter, ATCC=American Type Culture Collection, MBC=minimum biocidal concentration, and MIC=minimum inhibitory concentration. Unless otherwise specified, temperatures are in degrees centigrade (° C.), and references to percentages (%) are by weight. Amounts of organic microbicides are given on an active ingredient basis in ppm (w/w).

The compositions of the present invention unexpectedly have been found to provide enhanced microbicidal efficacy at a combined active ingredient level lower than that of the individual microbicides.

In one embodiment of the invention, the antimicrobial composition comprises N-methyl-1,2-benzisothiazolin-3-one and 2,2-dibromo-3-nitrilopropionamide. Preferably, a weight ratio of 2,2-dibromo-3-nitrilopropionamide to N-methyl-1,2-benzisothiazolin-3-one is from 1:0.01 to 1:114, more preferably from 1:0.01 to 1:29, more preferably from 0.02 to 1:5.8.

In one embodiment of the invention, the antimicrobial composition comprises N-methyl-1,2-benzisothiazolin-3-one and formaldehyde. Preferably, a weight ratio of formaldehyde to N-methyl-1,2-benzisothiazolin-3-one is from 1:0.0022 to 1:19, more preferably from 1:0.022 to 1:19, more preferably from 1:0.17 to 1:19.

In one embodiment of the invention, the antimicrobial composition comprises N-methyl-1,2-benzisothiazolin-3-one and 2-N-octyl-4-isothiazolin-3-one. Preferably, a weight ratio of 2-N-octyl-4-isothiazolin-3-one to N-methyl-1,2-benzisothiazolin-3-one is from 1:0.02 to 1:882, more preferably from 1:0.13 to 1:882, more preferably from 1:0.13 to 1:150.

In one embodiment of the invention, the antimicrobial composition comprises N-methyl-1,2-benzisothiazolin-3-one and propiconazole. Preferably, a weight ratio of propiconazole to N-methyl-1,2-benzisothiazolin-3-one is from 1:0.0022 to 1:6.8, more preferably from 1:0.075 to 1:6.8.

In one embodiment of the invention, the antimicrobial composition comprises N-methyl-1,2-benzisothiazolin-3-one and tebuconazole. Preferably, a weight ratio of tebuconazole to N-methyl-1,2-benzisothiazolin-3-one is from 1:0.0033 to 1:46, more preferably from 1:0.15 to 1:46.

In one embodiment of the invention, the antimicrobial composition comprises N-methyl-1,2-benzisothiazolin-3-one and a 3:1 mixture of chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one. Preferably, the mixture is about a 3:1 mixture, respectively. Preferably, a weight ratio of the mixture to N-methyl-1,2-benzisothiazolin-3-one is from 1:91 to 1:114.

The microbicides in the composition of this invention may be used “as is” or may first be formulated with a solvent or a solid carrier. Suitable solvents include, for example, water; glycols, such as ethylene glycol, propylene glycol, diethylene glycol, dipropylene glycol, polyethylene glycol, and polypropylene glycol; glycol ethers; alcohols, such as methanol, ethanol, propanol, phenethyl alcohol and phenoxypropanol; ketones, such as acetone and methyl ethyl ketone; esters, such as ethyl acetate, butyl acetate, triacetyl citrate, and glycerol triacetate; carbonates, such as propylene carbonate and dimethyl carbonate; and mixtures thereof. It is preferred that the solvent is selected from water, glycols, glycol ethers, esters and mixtures thereof. Suitable solid carriers include, for example, cyclodextrin, silicas, diatomaceous earth, waxes, cellulosic materials, alkali and alkaline earth (e.g., sodium, magnesium, potassium) metal salts (e.g., chloride, nitrate, bromide, sulfate) and charcoal.

When a microbicide component is formulated in a solvent, the formulation may optionally contain surfactants. When such formulations contain surfactants, they are generally in the form of emulsive concentrates, emulsions, microemulsive concentrates, or microemulsions. Emulsive concentrates form emulsions upon the addition of a sufficient amount of water. Microemulsive concentrates form microemulsions upon the addition of a sufficient amount of water. Such emulsive and microemulsive concentrates are generally well known in the art; it is preferred that such formulations are free of surfactants. U.S. Pat. No. 5,444,078 may be consulted for further general and specific details on the preparation of various microemulsions and microemulsive concentrates.

A microbicide component also can be formulated in the form of a dispersion. The solvent component of the dispersion can be an organic solvent or water, preferably water. Such dispersions can contain adjuvants, for example, co-solvents, thickeners, anti-freeze agents, dispersants, fillers, pigments, surfactants, biodispersants, sulfosuccinates, terpenes, furanones, polycations, stabilizers, scale inhibitors and anti-corrosion additives.

When both microbicides are each first formulated with a solvent, the solvent used for the first microbicide may be the same as or different from the solvent used to formulate the other commercial microbicide, although water is preferred for most industrial biocide applications. It is preferred that the two solvents are miscible.

Those skilled in the art will recognize that the microbicide components of the present invention may be added to a locus sequentially, simultaneously, or may be combined before being added to the locus. It is preferred that the first microbicide and the second microbicide component be added to a locus simultaneously or sequentially. When the microbicides are added simultaneously or sequentially, each individual component may contain adjuvants, such as, for example, solvent, thickeners, anti-freeze agents, colorants, sequestrants (such as ethylenediamine-tetraacetic acid, ethylenediaminedisuccinic acid, iminodisuccinic acid and salts thereof), dispersants, surfactants, biodispersants, sulfosuccinates, terpenes, furanones, polycations, stabilizers, scale inhibitors and anti-corrosion additives.

›DETAILED DESCRIPTION OF THE INVENTION · 2 of 2

The microbicidal compositions of the present invention can be used to inhibit the growth of microorganisms or higher forms of aquatic life (such as protozoans, invertebrates, bryozoans, dinoflagellates, crustaceans, mollusks, etc.) by introducing a microbicidally effective amount of the compositions onto, into, or at a locus subject to microbial attack. Suitable loci include, for example: industrial process water; electrocoat deposition systems,; cooling towers; air washers; gas scrubbers; mineral slurries; wastewater treatment; ornamental fountains; reverse osmosis filtration; ultrafiltration; ballast water; evaporative condensers; heat exchangers; pulp and paper processing fluids and additives; starch; plastics; emulsions; dispersions; paints; latices; coatings, such as varnishes; construction products, such as mastics, caulks, and sealants; construction adhesives, such as ceramic adhesives, carpet backing adhesives, and laminating adhesives; industrial or consumer adhesives; photographic chemicals; printing fluids; household products, such as bathroom and kitchen cleaners; cosmetics; toiletries; shampoos; soaps; detergents; industrial cleaners; floor polishes; laundry rinse water; metalworking fluids; conveyor lubricants; hydraulic fluids; leather and leather products; textiles; textile products; wood and wood products, such as plywood, chipboard, wallboard, flakeboard, laminated beams, oriented strandboard, hardboard, and particleboard; petroleum processing fluids; fuel; oilfield fluids, such as injection water, fracture fluids, and drilling muds; agriculture adjuvant preservation; surfactant preservation; medical devices; diagnostic reagent preservation; food preservation, such as plastic or paper food wrap; food, beverage, and industrial process pasteurizers; toilet bowls; recreational water; pools; and spas.

Preferably, the microbicidal compositions of the present invention are used to inhibit the growth of microorganisms at a locus selected from one or more of mineral slurries, pulp and paper processing fluids and additives, starch, emulsions, dispersions, paints, latices, coatings, construction adhesives, such as ceramic adhesives, carpet backing adhesives, photographic chemicals, printing fluids, household products such as bathroom and kitchen cleaners, cosmetics, toiletries, shampoos, soaps, detergents, industrial cleaners, floor polishes, laundry rinse water, metal working fluids, textile products, wood and wood products, agriculture adjuvant preservation, surfactant preservation, diagnostic reagent preservation, food preservation, and food, beverage, and industrial process pasteurizers.

The specific amount of the composition of this invention necessary to inhibit or control the growth of microorganisms and higher aquatic life forms in a locus depends upon the particular locus to be protected. Typically, the amount of the composition of the present invention to control the growth of microorganisms in a locus is sufficient if it provides from 0.1 to 1,000 ppm of the isothiazoline ingredient of the composition in the locus. It is preferred that the isothiazolone ingredients of the composition be present in the locus in an amount of at least 0.5 ppm, more preferably at least 4 ppm and most preferably at least 10 ppm. It is preferred that the isothiazolone ingredients of the composition be present in the locus in an amount of no more than 1000 ppm, more preferably no more than 500 ppm, and most preferably no more than 200 ppm.

›EXAMPLES

Materials and Methods

The synergism of the combination of the present invention was demonstrated by testing a wide range of concentrations and ratios of the compounds.

One measure of synergism is the industrially accepted method described by Kull, F. C.; Eisman, P. C.; Sylwestrowicz, H. D. and Mayer, R. L., in Applied Microbiology 9:538-541 (1961), using the ratio determined by the formula:

Q a /Q A +Q b /Q B =Synergy Index (“SI”)

wherein:

Q A =concentration of compound A (first component) in ppm, acting alone, which produced an end point (MIC of Compound A). Q a =concentration of compound A in ppm, in the mixture, which produced an end point. Q B =concentration of compound B (second component) in ppm, acting alone, which produced an end point (MIC of Compound B). Q b =concentration of compound B in ppm, in the mixture, which produced an end point.

When the sum of Q a /Q A and Q b /Q B is greater than one, antagonism is indicated. When the sum is equal to one, additivity is indicated, and when less than one, synergism is demonstrated. The lower the SI, the greater the synergy shown by that particular mixture. The minimum inhibitory concentration (MIC) of a microbicide is the lowest concentration tested under a specific set of conditions that prevents the growth of added microorganisms.

Synergy tests were conducted using standard microtiter plate assays with media designed for optimal growth of the test microorganism. Minimal salt medium supplemented with 0.2% glucose and 0.1% yeast extract (M9GY medium) was used for testing bacteria; Potato Dextrose Broth (PDB medium) was used for testing yeast and mold. In this method, a wide range of combinations of microbicides was tested by conducting high resolution MIC assays in the presence of various concentrations of MBIT. High resolution MICs were determined by adding varying amounts of microbicide to one column of a microtitre plate and doing subsequent ten-fold dilutions using an automated liquid handling system to obtain a series of endpoints ranging from 2 ppm to 10,000 ppm active ingredient.

The synergy of the combinations of the present invention was determined against a bacterium, Escherichia coli ( E. coli —ATCC #8739), a yeast, Candida albicans ( C. albicans —ATCC 10231), and a mold, Aspergillus niger ( A. niger —ATCC 16404). The bacteria were used at a concentration of about 5×10 6 bacteria per mL and the yeast and mold at 5×10 5 fungi per mL. These microorganisms are representative of natural contaminants in many consumer and industrial applications. The plates were visually evaluated for microbial growth (turbidity) to determine the MIC after various incubation times at 25° C. (yeast and mold) or 30° C. (bacteria).

The test results for demonstration of synergy of the MBIT combinations of the present invention are shown below in Tables 1 through 6. In each test, Second Component (B) was MBIT and the First Component (A) was the other commercial microbicide. Each table shows the specific combinations of MBIT and the other component; results against the microorganisms tested with incubation times; the end-point activity in ppm measured by the MIC for MBIT alone (Q B ), for the other component alone (Q A ), for MBIT in the mixture (Q b ) and for the other component in the mixture (Q a ); the calculated SI value; and the range of synergistic ratios for each combination tested (other component/MBIT or A/B).

›Tables in the description — 6
TABLE 1 — Contact Ratio: Ca:Cb
Test OrganismsTimeCaCbS.I.Ca:Cb
A. niger
3 days1.275———
ATCC # 16404—150——
0.6750.971:125.0000
0.9751.211:83.3333
0.91.20.711:1.3333
1.2751.21.011:0.9412
C. albicans
48 hrs1.275———
ATCC # 10231—30——
1.2751.861.061:1.4588
1.2750.941.031:0.7373
72 hrs1.275———
—30——
1.2751.861.061:1.4588
1.2750.941.031:0.7373
Ps. aeruginosa
24 hrs1.275———
ATCC # 9027—100——
1.27561.061:4.7059
48 hrs1.275———
—175——
0.61001.041:166.6667
S. aureus
48 hrs0.9———
ATCC # 6538—60——
0.2625300.791:114.2857
0.33300.871:90.9091
0.6301.171:50.0000
Ca—ppm AI of CMI/MI (Chloro-2-methyl-4-isothiazolin-3-one/2-Methyl-4-isothiazolin-3-one)
Cb—ppm AI of MBIT (N-methyl-1,2-benzisothiazolin-3-one)
TABLE 2 — Contact Ratio: Ca:Cb
Test OrganismsTimeCaCbS.I.Ca:Cb
A. niger
3 days42.5———
ATCC # 16404—9.4——
4.254.70.601:1.1059
5.254.70.621:0.8952
8.754.70.711:0.5371
114.70.761:0.4273
204.70.971:0.2350
304.71.211:0.1567
4.252.40.361:0.5647
5.252.40.381:0.4571
8.752.40.461:0.2743
112.40.511:0.2182
202.40.731:0.1200
302.40.961:0.0800
42.52.41.261:0.0565
4.251.20.231:0.2824
5.251.20.251:0.2286
8.751.20.331:0.1371
111.20.391:0.1091
201.20.601:0.0600
301.20.831:0.0400
42.51.21.131:0.0282
7 days200———
—18.8——
42.59.40.711:0.2212
52.59.40.761:0.1790
659.40.831:0.1446
87.59.40.941:0.1074
1109.41.051:0.0855
87.54.70.691:0.0537
1104.70.801:0.0427
2004.71.251:0.0235
652.40.451:0.0369
87.52.40.571:0.0274
1102.40.681:0.0218
2002.41.131:0.0120
87.51.20.501:0.0137
1101.20.611:0.0109
2001.21.061:0.0060
C. albicans
48 hrs44———
ATCC # 10231—30——
2.6150.561:5.7692
4.4150.601:3.4091
8150.681:1.8750
12150.771:1.2500
17150.891:0.8824
21150.981:0.7143
26151.091:0.5769
87.50.431:0.9375
127.50.521:0.6250
177.50.641:0.4412
217.50.731:0.3571
267.50.841:0.2885
447.51.131:0.1705
443.751.061:0.0852
351.860.861:0.0531
441.861.031:0.0423
440.941.031:0.0214
72 hrs>44——
30——
4.4150.61:3.4091
8150.681:1.8750
12150.771:1.2500
17150.891:0.8824
21150.981:0.7143
26151.091:0.5769
87.50.431:0.9375
127.50.521:0.6250
177.50.641:0.4412
217.50.731:0.3571
267.50.841:0.2885
447.51.251:0.1705
351.860.861:0.0531
441.861.061:0.0423
440.941.031:0.0214
Ps. Aeruginosa
24 hrs4.25——
ATCC # 9027100——
2500.971:25.0000
3501.211:16.6667
3250.961:8.3333
4.25251.251:5.8824
4.2561.061:1.4118
48 hrs5.25———
—175——
0.8751000.741:114.2857
1.11000.781:90.9091
21000.951:50.0000
31001.141:33.3333
5.25121.071:2.2857
S. aureus
48 hrs8.5——
ATCC # 653860——
1.05300.621:28.5714
4300.971:7.5000
6301.211:5.0000
4150.721:3.7500
6150.961:2.5000
8.5151.251:1.7647
620.741:0.3333
8.521.031:0.2353
610.721:0.1667
8.511.021:0.1176
Ca—ppm AI of DBNPA (2,2-Dibromo-3-nitrilopropionamide)
Cb—ppm AI of MBIT(N-methyl-1,2-benzisothiazolin-3-one)
TABLE 3 — Ratio: Ca:Cb
TestContact
OrganismsTimeCaCbS.I.Ca:Cb
A. niger
3 days200———
ATCC # 16404—75——
237.50.511:18.7500
5.2537.50.531:7.1429
8.7537.50.541:4.2857
1137.50.561:3.4091
2037.50.601:1.8750
3037.50.651:1.2500
42.537.50.711:0.8824
52.537.50.761:0.7143
6537.50.831:0.5769
87.537.50.941:0.4286
11037.51.051:0.3409
42.518.80.461:0.4424
52.518.80.511:0.3581
6518.80.581:0.2892
87.518.80.691:0.2149
11018.80.801:0.1709
20018.81.251:0.0940
659.40.451:0.1446
87.59.40.561:0.1074
1109.40.681:0.0855
2009.41.131:0.0470
87.54.70.501:0.0537
1104.70.611:0.0427
2004.71.061:0.0235
1102.40.581:0.0218
2002.41.031:0.0120
2001.21.021:0.0060
7 days425———
—150——
65750.651:1.1538
87.5750.711:0.8571
110750.761:0.6818
200750.971:0.3750
300751.211:0.2500
30037.50.961:0.1250
42537.51.251:0.0882
20018.80.61:0.0940
30018.80.831:0.0627
42518.81.131:0.0442
4259.41.061:0.0221
4254.71.031:0.0111
3002.40.721:0.0080
4252.41.021:0.0056
3001.20.711:0.0040
4251.21.011:0.0028
C. albicans
48 hrs425———
ATCC # 10231—30——
87.5150.711:0.1714
110150.761:0.1364
200150.971:0.0750
300151.211:0.0500
8757.52.311:0.0086
3003.750.831:0.0125
4253.751.131:0.0088
3001.860.771:0.0062
4251.861.061:0.0044
4250.941.031:0.0022
72 hrs525———
—30——
110150.711:0.1364
200150.881:0.0750
300151.071:0.0500
3003.750.701:0.0125
4253.750.931:0.0088
5253.751.131:0.0071
4251.860.871:0.0044
5251.861.061:0.0035
4250.940.841:0.0022
5250.941.031:0.0018
Ps. aeruginosa
24 hrs15———
ATCC # 9027—100——
1561.061:0.4000
48 hrs26.25———
—175——
101000.951:10.0000
151001.141:6.6667
15500.861:3.3333
21.25501.101:2.3529
21.25250.951:1.1765
26.25251.141:0.9524
21.25120.881:0.5647
26.25121.071:0.4571
21.2560.841:0.2824
26.2561.031:0.2286
S. aureus
24 hrs30———
ATCC # 6538—60——
3300.601:10.0000
5.25300.681:5.7143
11300.871:2.7273
20301.171:1.5000
20150.921:0.7500
30151.251:0.5000
3031.051:0.1000
3021.031:0.0667
3011.021:0.0333
48 hrs30———
—60——
5.25300.681:5.7143
11300.871:2.7273
20301.171:1.5000
20150.921:0.7500
3031.051:0.1000
3021.031:0.0667
3011.021:0.0333
Ca—ppm AI of HCHO (Formaldehyde)
Cb—ppm AI of MBIT(N-methyl-1,2-benzisothiazolin-3-one)
TABLE 4 — Ratio: Ca:Cb
TestContact
OrganismsTimeCaCbS.I.Ca:Cb
A. niger
3 days0.65———
ATCC # 16404—75——
0.042537.50.571:882.3529
0.06537.50.601:576.9231
0.1137.50.671:340.9091
0.237.50.811:187.5000
0.337.50.961:125.0000
0.42537.51.151:88.2353
0.52518.81.061:35.8095
0.5259.40.931:17.9048
0.659.41.131:14.4615
0.5254.70.871:8.9524
0.654.71.061:7.2308
0.652.41.031:3.6923
0.651.21.021:1.8462
7 days8.75———
—150——
0.5251501.061:285.7143
1.1750.631:68.1818
2750.731:37.5000
3750.841:25.0000
4.25750.991:17.6471
5.25751.101:14.2857
237.50.481:18.7500
337.50.591:12.5000
4.2537.50.741:8.8235
5.2537.50.851:7.1429
6.537.50.991:5.7692
8.7537.51.251:4.2857
0.87518.80.231:21.4857
1.118.80.251:17.0909
218.80.351:9.4000
318.80.471:6.2667
4.2518.80.611:4.4235
6.518.80.871:2.8923
8.7518.81.131:2.1486
29.40.291:4.7000
39.40.411:3.1333
4.259.40.551:2.2118
5.259.40.661:1.7905
6.59.40.811:1.4462
8.759.41.061:1.0743
24.70.261:2.3500
34.70.371:1.5667
4.254.70.521:1.1059
5.254.70.631:0.8952
6.54.70.771:0.7231
8.754.71.031:0.5371
5.252.40.621:0.4571
6.52.40.761:0.3692
8.752.41.021:0.2743
5.251.20.611:0.2286
6.51.20.751:0.1846
8.751.21.011:0.1371
C. albicans
48 hrs3.25——
ATCC # 10231—30——
2.6257.51.061:2.8571
2.6253.750.931:1.4286
3.253.751.131:1.1538
3.251.861.061:0.5723
3.250.941.031:0.2892
72 hrs3.25———
—30——
3.251.861.061:0.5723
3.250.941.031:0.2892
Ps. aeruginosa
24 hrs650———
ATCC # 9027—100——
525251.061:0.0476
525120.931:0.0229
650121.121:0.0185
65061.061:0.0092
48 hrs650———
—175——
2001000.881:0.5000
3001001.031:0.3333
525501.091:0.0952
525250.951:0.0476
650251.141:0.0385
650121.071:0.0185
65061.031:0.0092
S. aureus
24 hrs30———
ATCC # 6538—30——
3150.601:5.0000
5.25150.681:2.8571
6.5150.721:2.3077
8.75150.791:1.7143
11150.871:1.3636
20151.171:0.7500
207.50.921:0.3750
307.51.251:0.2500
3021.071:0.0667
3011.031:0.0333
48 hrs200———
—60——
0.2300.501:150.0000
2300.511:15.0000
20300.601:1.5000
30300.651:1.0000
42.5300.711:0.7059
52.5300.761:0.5714
87.5300.941:0.3429
110301.051:0.2727
4.25150.271:3.5294
2150.261:7.5000
20150.351:0.7500
30150.401:0.5000
42.5150.461:0.3529
52.5150.511:0.2857
87.5150.691:0.1714
110150.801:0.1364
200151.251:0.0750
207.50.231:0.3750
307.50.281:0.2500
42.57.50.341:0.1765
52.57.50.391:0.1429
87.57.50.561:0.0857
1107.50.681:0.0682
2007.51.131:0.0375
87.530.491:0.0343
11030.61:0.0273
20031.051:0.0150
20021.031:0.0100
20011.021:0.0050
Ca—ppm AI of OIT (2-N-octyl-4-isothiazolin-3-one)
Cb—ppm AI of MBIT(N-methyl-1,2-benzisothiazolin-3-one)
TABLE 5 — Ratio: Ca:Cb
TestContact
OrganismsTimeCaCbS.I.Ca:Cb
A. niger
3 days52.5———
ATCC # 16404—37.5——
6.518.80.631:2.8923
1118.80.711:1.7091
2018.80.881:0.9400
3018.81.071:0.6267
52.52.41.061:0.0457
52.51.21.031:0.0229
7 days87.5———
—150——
11750.631:6.8182
20750.731:3.7500
30750.841:2.5000
42.5750.991:1.7647
52.5751.101:1.4286
42.537.50.741:0.8824
52.537.50.851:0.7143
6537.50.991:0.5769
52.518.80.731:0.3581
6518.80.871:0.2892
87.518.81.131:0.2149
87.59.61.061:0.1097
87.54.71.031:0.0537
87.52.41.021:0.0274
87.51.21.011:0.0137
C. albicans
48 hrs525———
ATCC # 10231—30——
8.75150.521:1.7143
20150.541:0.7500
42.5150.581:0.3529
65150.621:0.2308
110150.711:0.1364
200150.881:0.0750
300151.071:0.0500
657.50.371:0.1154
1107.50.461:0.0682
2007.50.631:0.0375
3007.50.821:0.0250
4257.51.061:0.0176
2003.750.511:0.0188
3003.750.701:0.0125
4253.750.931:0.0088
5253.751.131:0.0071
2001.860.441:0.0093
3001.860.631:0.0062
4251.860.871:0.0044
5251.861.061:0.0035
4250.940.841:0.0022
5250.941.031:0.0018
72 hrs525———
—30——
8.75150.521:1.7143
20150.541:0.7500
42.5150.581:0.3529
65150.621:0.2308
110150.711:0.1364
200150.881:0.0750
300151.071:0.0500
657.50.371:0.1154
1107.50.461:0.0682
2007.50.631:0.0375
3007.50.821:0.0250
4257.51.061:0.0176
2003.750.511:0.0188
3003.750.701:0.0125
4253.750.931:0.0088
5253.751.131:0.0071
2001.860.441:0.0093
3001.860.631:0.0062
4251.860.871:0.0044
5251.861.061:0.0035
4250.940.841:0.0022
5250.941.031:0.0018
Ps. Aeruginosa
24 hrs875———
ATCC # 9027—100——
650250.991:0.0385
87561.061:0.0069
48 hrs875———
—175——
875121.071:0.0137
87561.031:0.0069
S. aureus
24 hrs1100———
ATCC # 6538—30——
200150.681:0.0750
300150.771:0.0500
425150.891:0.0353
525150.981:0.0286
650151.091:0.0231
8757.51.051:0.0086
87530.901:0.0034
110031.11:0.0027
110021.071:0.0018
110011.031:0.0009
48 hrs1100———
—60——
200150.431:0.0750
300150.521:0.0500
425150.641:0.0353
525150.731:0.0286
650150.841:0.0231
875151.051:0.0171
8757.50.921:0.0086
11007.51.131:0.0068
87530.851:0.0034
110031.051:0.0027
110021.031:0.0018
110011.021:0.0009
Ca—ppm AI of Propiconazole (1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole)
Cb—ppm AI of MBIT(N-methyl-1,2-benzisothiazolin-3-one
TABLE 6 — Ratio: Ca:Cb
TestContact
OrganismsTimeCaCbS.I.Ca:Cb
A. niger
3 days4.25———
ATCC # 16404—37.5——
1.118.80.761:17.0909
218.80.971:9.4000
7 days11———
—150——
112.41.021:0.2182
111.21.011:0.1091
C. albicans
48 hrs110———
ATCC # 10231—30——
42.5150.891:0.3529
52.5150.981:0.2857
65151.091:0.2308
87.57.51.051:0.0857
1101.861.061:0.0169
1100.941.031:0.0085
72 hrs110———
—30——
42.5150.891:0.3529
52.5150.981:0.2857
65151.091:0.2308
87.57.51.051:0.0857
1101.861.061:0.0169
1100.941.031:0.0085
Ps. aeruginosa
24 hrs875———
ATCC # 9027—100——
650250.991:0.0385
87561.061:0.0069
48 hrs1100———
—175——
875501.081:0.0571
875250.941:0.0286
1100251.141:0.0227
1100121.071:0.0109
110061.031:0.0055
S. aureus
24 hrs300———
ATCC # 6538—30——
87.5150.791:0.1714
110150.871:0.1364
200151.171:0.0750
2007.50.921:0.0375
3007.51.251:0.0250
20030.771:0.0150
20020.731:0.0100
30021.071:0.0067
20010.701:0.0050
30011.031:0.0033
48 hrs425———
—60——
0.65300.501:46.1538
2300.501:15.0000
4.25300.511:7.0588
6.5300.521:4.6154
11300.531:2.7273
20300.551:1.5000
30300.571:1.0000
42.5300.601:0.7059
52.5300.621:0.5714
65300.651:0.4615
87.5300.711:0.3429
110300.761:0.2727
200300.971:0.1500
300301.211:0.1000
87.5150.461:0.1714
110150.511:0.1364
200150.721:0.0750
300150.961:0.0500
425151.251:0.0353
2007.50.61:0.0375
3007.50.831:0.0250
4257.51.131:0.0176
20030.521:0.0150
30030.761:0.0100
42531.051:0.0071
20020.51:0.0100
30020.741:0.0067
42521.031:0.0047
20010.491:0.0050
30010.721:0.0033
42511.021:0.0024
Ca—ppm AI of Tebuconazole (alpha-[2-(4-chlorophenyl)ethyl]-alpha-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol)
Cb—ppm AI of MBIT (N-methyl-1,2-benzisothiazolin-3-one)
1 of 5 part labels are ours — the grant heads the rest

Claims as granted

2 claims

Log in to read the claims of this application.

Log in to unlock

Classifications

3 codes
IPC · International Patent Classification
Section A — Human necessities
  • A01N43/80
  • A01P1/00
USPC · US Patent Classification
514/373

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this application are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoom200920102011201220132014USPTOApplicantNon-final rejectionNotice of appeal filedNotice of allowance
USPTOApplicanthover for detail · click to open
Pendency
5.7 y
2,077 days filing → grant
Office actions
2
non-final + final
Responses
1
no RCE
Appeals
1
notices of appeal
Examiner
Daniel Sullivan
art unit 1611 · TC 1600
Citations: 4 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Documents

Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.

Log in to unlock

Chain of title

⤢ drag to zoom20142016201820202022202420262028Owner 1Owner 3
Titlehover for detail · click to open

See the full assignment history — every owner this patent has passed through, with recordation dates and reel/frame numbers.

Log in to unlock